Ameliorative Effects of Extracellular Vesicles Derived from Mesenchymal Stem Cells on Apoptosis and Differentiation of Osteoblasts Treated with CoCl 2
Cellular Reprogramming · 2023
DOI: 10.1089/cell.2023.0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Reprogramming, 2023. Verfasst von Qicheng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China.
- Key Laboratory of Trauma and Neural Regeneration (Peking University), Ministry of Education, Beijing, China.
- Department of Hand Surgery, Beijing Jishuitan Hospital, Beijing, China.
- National Center of Trauma Medicine, Beijing, China.
ORCID-Profile: Na Han
Zitieren
APA
Li, Q., Zhang, W., Deng, J., Li, Q., Fu, X., Kou, Y., & Han, N. (2023). Ameliorative Effects of Extracellular Vesicles Derived from Mesenchymal Stem Cells on Apoptosis and Differentiation of Osteoblasts Treated with CoCl 2. Cellular Reprogramming. https://doi.org/10.1089/cell.2023.0001
Vancouver
Li Q, Zhang W, Deng J, Li Q, Fu X, Kou Y, et al. Ameliorative Effects of Extracellular Vesicles Derived from Mesenchymal Stem Cells on Apoptosis and Differentiation of Osteoblasts Treated with CoCl 2. Cellular Reprogramming. 2023. doi:10.1089/cell.2023.0001
BibTeX
@article{Li2023,
author = {Li, Qicheng and Zhang, Wei and Deng, Jin and Li, Qiuya and Fu, Xiaoyang and Kou, Yuhui and Han, Na},
title = {Ameliorative Effects of Extracellular Vesicles Derived from Mesenchymal Stem Cells on Apoptosis and Differentiation of Osteoblasts Treated with CoCl 2},
journal = {Cellular Reprogramming},
year = {2023},
doi = {10.1089/cell.2023.0001}
}
EUVIMED